Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer

Autor: Joep G.H. van Roermund, Moniek W. M. van de Luijtgaarden, H.F.M. Karthaus, Lambertus A. Kiemeney, J. Alfred Witjes, Katja K.H. Aben, Dieuwertje E. Kok, Ellen Kampman, Oncko B. van Vierssen Trip

Publikováno v: World Journal of Urology, 29(5), 695-701
World journal of urology, 29(5), 695-701. Springer Verlag
World Journal of Urology, 29, 5, pp. 695-701
World Journal of Urology
World Journal of Urology 29 (2011) 5
World Journal of Urology, 29, 695-701

Contains fulltext : 95677.pdf (Publisher’s version ) (Closed access) PURPOSE: To determine the effect of body mass index (BMI) on clinical and pathological characteristics at time of diagnosis and on risk of biochemical recurrence after radical pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a88dbc06d4f99c55b13fa39201d157
https://doi.org/10.1007/s00345-010-0629-0

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Autor: Oncko B. van Vierssen Trip, Viktor Vik, Ingrid van der Putten-Slob, Christopher R. Chapple, Roberto Mario Scarpa, Bernard Gattegno, Simon Holmes, Salman Al-Shukri, José M. Martínez-Sagarra

Publikováno v: European Urology Supplements. 4:33-44

Objectives: This phase 3a study assessed the efficacy and safety of two different doses of a new formulation of tamsulosin (the oral controlled absorption system: OCAS) in comparison with placebo and the old modified release (MR) formulation of tamsu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e1b2232414765c90c9c6116fc8dcec4
https://doi.org/10.1016/j.eursup.2004.10.010